Anti-CD14 therapeutic (Deka Biosciences)

N/A

Report date: 2025/03/14 16:48:37

Base Information

Drug NameAnti-CD14 therapeutic (Deka Biosciences)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-4 modulatorsMonocyte differentiation antigen CD14 modulatorsInterleukin-10 modulators
TargetsMonocyte differentiation antigen CD14Interleukin-4Interleukin-10
Therapy Area/IndicationsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDeka Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesDeka Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A